U.S. Markets closed

Kraig Biocraft Laboratories, Inc. (KBLB)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1528-0.0014 (-0.91%)
At close: 3:56PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.1542
Open0.1540
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1490 - 0.1586
52 Week Range0.1100 - 0.3300
Volume1,119,416
Avg. Volume1,597,155
Market Cap130.554M
Beta (5Y Monthly)0.20
PE Ratio (TTM)N/A
EPS (TTM)-0.0060
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Kraig Biocraft Laboratories Celebrates Arbor Day by Funding Planting of more than 100,000 Mulberry Trees

    Kraig Labs honors its commitment to eco-responsible Spider Silk production with significant expansion of tree plantingANN ARBOR, Mich., April 30, 2021 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, honors Arbor Day by funding the planting of more than 100,000 mulberry trees. While playing a vital role in purifying our air and stabilizing the soil, these trees also serve as a valuable, sustainable resource for the production of the Company’s proprietary spider silk technology. The Company believes that in pledging to do what is right for the environment, it can strengthen its business and expand future opportunities. Kraig Labs' business model is built on the utilization of renewable and sustainable mulberry leaves for the production of recombinant spider silk. Under the care of Prodigy Textiles, the Company’s Vietnamese subsidiary, these trees are already supporting production operations and will continue to play a significant role in the commercialization of Company’s recombinant spider silk technologies. “Through thoughtful design of our production systems, with an eye towards energy efficiency, a reduction in inorganic materials, and a low carbon footprint, we created a system that is in line with long honored cultural traditions, where eco-responsibly is a valuable byproduct of doing what is best for our business and our shareholders,” said Jon Rice, COO. “I am proud of the work our team has done to contribute to the more than two million acres of mulberry trees planted globally, as part of our efforts to bring materials of unparalleled performance to the textile markets.” To view the most recent news from Kraig Labs, including recent mulberry tree pictures at one of its co-op tree farms, and/or to sign up for Company alerts, please go to www.KraigLabs.com/news. About Kraig Biocraft Laboratories, Inc. Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company, is a developer of genetically engineered spider silk based fiber technologies. Cautionary Statement Regarding Forward Looking Information Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security. Ben Hansel, Hansel Capital, LLC(720) 288-8495ir@KraigLabs.com

  • GlobeNewswire

    Kraig Biocraft Laboratories subsidiary, Spydasilk Enterprises, files for registration of multiple Spider Silk brand trademarks

    Kings Group, Kraig’s joint venture partner, leads branding, with unique trademarks centered on spider silkANN ARBOR, Mich., April 22, 2021 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, announces that Spydasilk Enterprises Pte. Ltd. (“Spydasilk Enterprises”), the Company’s Singapore based joint venture, with M the Movement and Kings Golden Harvest Pte Ltd (collectively, “Kings Group”), has applied for its first four Spydasilk brand trademarks with the US Patent and Trademark office. These first four trademarks include brand and product specific marking that Spydasilk Enterprises will use in the branding and marketing of its yarns, textiles, and finished garments. “Our goal was to design the Spydasilk trademarks to be clean, distinctive, and powerful, able to stand alone or work in collaboration with co-branding opportunities with potential product partners. I think that our design team delivered on all four of these criteria, creating a memorable brand with the unique inspired design,” said Walter Wee, CIO of Kings Group. In addition to Spydasilk Enterprises developing a premium apparel, based on Kraig Labs’ spider silk technologies, Kraig Labs and Kings Group are simultaneously building other spider silk sales markets outside of apparel and textiles. With that in mind, the companies are working quickly to build Spydasilk Enterprises’ down channel distribution network. These additional markets are expected to further expand the previously announced exclusive purchase and sales agreement, valued at up to US$40 million. “SpydaSilk is obviously a unique enterprise, so we wanted to create trademarks that highlight the technology at the center of the brand. These trademarks provide distinctive styling that will help our customers easily identify Spydasilk’s product and the performance driven technologies at the heart of their design,” said Kim Thompson, Kraig Labs’ founder and CEO. To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news. About Kings Group and M the Movement Kings Group is headquartered in Singapore and established regional offices with multiple assets in Indonesia and Vietnam. Kings Group envisions itself to be a forerunner in International Marketing and Trading; bridging domestic businesses and projecting their products internationally. For further information, please visit www.kings.com.sg. M the Movement is Kings Group’s premiere eco-friendly luxury streetwear line. Internationally recognized and loved by celebrities globally. For more information, please visit www.mthemovement.com About Kraig Biocraft Laboratories, Inc. Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company, is a developer of genetically engineered spider silk based fiber technologies. Cautionary Statement Regarding Forward Looking Information Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security. Ben Hansel, Hansel Capital, LLC(720) 288-8495ir@KraigLabs.com

  • GlobeNewswire

    Kraig Biocraft Laboratories and Kings Group form Spydasilk Enterprises Pte. Ltd., a Singapore based Joint Venture Company, for the marketing and sales of spider silk based products

    Kraig’s joint venture with Kings is tied to the previously announced exclusive spider silk purchase and sales agreement valued at up to US$40 millionANN ARBOR, Mich., April 09, 2021 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, announces that the Company, together with M the Movement, Kings Golden Harvest Pte Ltd (“Kings Group”), has established Spydasilk Enterprises Pte. Ltd. (“Spydasilk Enterprises”) as a Singapore based joint venture. This partnership represents the Company’s first vertically integrated sales channel. Spydasilk Enterprises is developing a premium line of luxury streetwear based on Kraig Labs’ spider silk technologies with exclusive sales rights within the Association of Southeast Asian Nations (ASEAN) region. The move positions Kraig Labs and Kings Group to advance their partnership, which began with a previously announced exclusive purchase and sales agreement valued at up to US$40 million. “Based on our initial efforts, there is a definite demand for spider silk technology and product developers are very excited about working with these super fibers,” said Walter Wee, CIO of Kings Group. “In addition to building up the Spydasilk brand, we must build Spydasilk’s vendor and customer bases. We are already having great success with clients that share our vision and passion for spider silk. We believe that their efforts will further broaden Spydasilk’s market opportunities in multiple industries asides from the fashion industry,” continued Wee. The new joint venture company will commercialize Kraig Labs’ biodegradable and biocompatible ‘super fibers’, using a scalable and cost-effective spider silk production platform and patented spider silk gene sequences in silkworms. “This new joint venture is the beginning of the fulfillment of my original vision for Kraig Labs, where we are able to vertically integrate and capture intermediate and end product margins. Thanks to Walter and the Kings Group team, Spydasilk should hit the ground running. We have high expectations for the future of spider silk and Spydasilk Enterprises,” said Kim Thompson, Kraig Labs’ founder and CEO. To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news. About Kings Group and M the Movement Kings Group is headquartered in Singapore and established regional offices with multiple assets in Indonesia and Vietnam. Kings Group envisions itself to be a forerunner in International Marketing and Trading; bridging domestic businesses and projecting their products internationally. For further information, please visit www.kings.com.sg. M the Movement is Kings Group’s premiere eco-friendly luxury streetwear line. Internationally recognized and loved by celebrities globally. For more information, please visit www.mthemovement.com About Kraig Biocraft Laboratories, Inc. Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company, is a developer of genetically engineered spider silk based fiber technologies. Cautionary Statement Regarding Forward Looking Information Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward-looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security. Ben Hansel, Hansel Capital, LLC(720) 288-8495ir@KraigLabs.com